The role of top management teams in the development of resources and capabilities Online publication date: Tue, 01-Jul-2003
by Laura B. Cardinal, Donald E. Hatfield, Helaine J. Korn
International Journal of Healthcare Technology and Management (IJHTM), Vol. 4, No. 5, 2002
Abstract: In this manuscript, we bridge two important, but often separate, streams of strategy research on the core competence perspective and upper echelons theory. We develop a model of how top management team characteristics influence the choices made concerning resources and capabilities pursued by pharmaceutical firms and how those choices impact innovative productivity. In particular, we propose how top management team tenure, education level and functional background, as well as heterogeneity in top management team tenure and functional background, influence product line breadth and the frequency of new product market entry, in-house R&D efforts and strategic alliances.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Healthcare Technology and Management (IJHTM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com